Detalhe da pesquisa
1.
Trial of Intravenous Immune Globulin in Dermatomyositis.
N Engl J Med
; 387(14): 1264-1278, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198179
2.
Paraproteinemic neuropathies.
Muscle Nerve
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38816958
3.
Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events.
Muscle Nerve
; 69(1): 87-92, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990374
4.
Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts.
Muscle Nerve
; 69(3): 273-287, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174864
5.
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study.
Eur J Neurol
; 31(1): e16098, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843174
6.
Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review.
Int J Mol Sci
; 25(7)2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612579
7.
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
N Engl J Med
; 383(10): 919-930, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877582
8.
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy.
BMC Neurol
; 23(1): 108, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932361
9.
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.
Heart Fail Rev
; 27(3): 785-793, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609196
10.
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial.
J Neurol Neurosurg Psychiatry
; 2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577511
11.
Factors associated with increased health-related quality-of-life benefits in hereditary transthyretin amyloidosis polyneuropathy patients treated with inotersen.
Muscle Nerve
; 66(3): 319-328, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766224
12.
Long-term treatment effects of inotersen on health-related quality of life in patients with hATTR amyloidosis with polyneuropathy: Analysis of the open-label extension of the NEURO-TTR trial.
Muscle Nerve
; 66(4): 438-446, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35799473
13.
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.
Muscle Nerve
; 66(1): 50-62, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428982
14.
Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.
Muscle Nerve
; 64(3): 243-254, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260074
15.
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Muscle Nerve
; 63(1): 31-39, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063909
16.
CIDP mimics: a case series.
BMC Neurol
; 21(1): 94, 2021 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639867
17.
Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
BMC Neurol
; 21(1): 70, 2021 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579211
18.
Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis.
Muscle Nerve
; 62(4): 509-515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654156
19.
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Muscle Nerve
; 59(2): 201-207, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30192007
20.
Pain, sleep, fatigue, and activities of daily living in patients with neuropathy.
Muscle Nerve
; 66(4): 380-381, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35919957